Please login to the form below

Not currently logged in
Email:
Password:

patient enrolment

This page shows the latest patient enrolment news and features for those working in and with pharma, biotech and healthcare.

Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval

Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval

patient population for Aduhelm of approximately one to two million people, according to the companies. ... to address pricing in order to achieve both patient access and support budget sustainability.”.

Latest news

  • RedHill Biopharma advances phase 2/3 COVID-19 programme RedHill Biopharma advances phase 2/3 COVID-19 programme

    With the study now approved in the UK and Russia, and additional approvals expected in the coming weeks, patient enrolment is planned to commence later this month,” said Aida Bibliowicz, vice

  • Entering the era of digital trials Entering the era of digital trials

    At the same time, the data explosion and emergence of automated analytical tools have raised expectations that the industry can crack the patient enrolment conundrum and other persistent problems. ... It is at this stage in the process that smartphone

  • Viking throws down gauntlet in NASH battle Viking throws down gauntlet in NASH battle

    The caveat of course is that the two trials have different enrolment criteria and patient baseline characteristics – in fact Madrigal’s trial was much bigger with around 150 patients versus

  • Merck suspends two Keytruda trials after patient deaths Merck suspends two Keytruda trials after patient deaths

    Investigators to look at Keytruda with Pomalyst and Revlimid. Merck &Co has paused patient enrolment in two trials of Keytruda to allow investigators to explore reports of deaths among patients taking

  • Trials of AZ's durvalumab restart as FDA hold is relaxed Trials of AZ's durvalumab restart as FDA hold is relaxed

    Patient recruitment can restart in two trials of AstraZeneca's PD-L1 inhibitor durvalumab placed under temporary suspension by the FDA, says the company. ... The phase III KESTREL trial has already re-opened for new patient enrolment at some clinical

More from news
Approximately 1 fully matching, plus 33 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...